Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL5090 Target Snapshot

Sterol 14alpha-demethylase · SINGLE PROTEIN · Mycobacterium tuberculosis

30Compounds
5Assays
5Approved Drugs
20.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P9WPP9. Use UniProt P9WPP9 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P9WPP9 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Sterol 14alpha-demethylase as ChEMBL target CHEMBL5090, mapped to UniProt P9WPP9. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Sterol 14alpha-demethylase
SINGLE PROTEIN · Mycobacterium tuberculosis
As of 2026-09-13
ChEMBL target ID
CHEMBL5090
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P9WPP9
Sterol 14alpha-demethylase
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Sterol 14alpha-demethylase is the right protein anchor across sources, using UniProt P9WPP9 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelSterol 14alpha-demethylase
UniProt AccessionP9WPP9
Component TypeProtein
Sequence Length451 aa

Sterol 14alpha-demethylase

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Sterol 14alpha-demethylase, mapped to UniProt P9WPP9. Sequence length is 451 aa.

Mapped IDP9WPP9
Review nameSterol 14alpha-demethylase
OrganismMycobacterium tuberculosis
Clinical Profile

Clinical Phase Distribution

5
Approved
Assay Mix

Activity Type Distribution

KD20.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL91 6.7 Kd 200.0 Approved
CHEMBL104 6.7 Kd 200.0 Approved
CHEMBL106 6.7 Kd 200.0 Approved
CHEMBL808 6.7 Kd 200.0 Approved
CHEMBL14145 5.89 Kd 1300.0 Preclinical
CHEMBL183282 5.3 Kd 5000.0 Preclinical
CHEMBL507264 5.3 Kd 5000.0 Preclinical
CHEMBL489925 5.3 Kd 5000.0 Preclinical
CHEMBL490941 5.3 Kd 5000.0 Preclinical
CHEMBL455684 5.3 Kd 5000.0 Preclinical
Distribution

pChEMBL Value Distribution

7
5.0
1
5.5
0
6.0
4
6.5
0
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

FLUCONAZOLE
CHEMBL106
Approved 1990
ECONAZOLE
CHEMBL808
Approved 1982
CLOTRIMAZOLE
CHEMBL104
Approved 1975
MICONAZOLE
CHEMBL91
Approved 1974
Assay Landscape

Assay Landscape

5
Total Assays
17
Tested Compounds
1
Assay Types
Binding — 5 assays, 17 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 4 13 4.9
single protein format 1 4 6.7

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine